<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046743">
  <TermName>PNU 166148</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called topoisomerase inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>PNU 166148</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de c√°ncer. Pertenece al tipo de medicamentos llamados inhibidores de la topoisomerasa.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2005-02-15</DateLastModified>
</GlossaryTerm>
